Survey of Irrational Use of Anti-tumor Immune Enhancement Drugs
- VernacularTitle:辅助抗肿瘤免疫增强药物不合理用药调查
- Author:
Jiaqin GU
;
Jun ZHU
- Keywords:
Adjuvant anti-tumor;
Immune enhancement drugs;
Irrational drug use
- From:
China Pharmacist
2017;20(1):130-132
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate and analyze the rational use of anti-tumor immune enhancement drugs in our hospital. Meth-ods:The annual use data of anti-tumor immune enhancement drugs in our hospital in 2015 were collected, and then statistically ana-lyzed and evaluated combing with the medical history information. Results: There were 12 varieties and 19 specifications of adjuvant anti-tumor immune enhancement drugs in our hospital, which accounted for 15. 87% of the total sum. Totally 25 481 patients used ad-juvant anti-tumor immune enhancement drugs, which occupied 29. 84% of the total medicine afford. The adjuvant anti-tumor immune enhancement drugs showed lots of irrational use in clinics, and the main irrationity was overuse and off-label use. Conclusion: It is necessary to strengthen prescription evaluation for anti-tumor immune enhancement drugs, which needs controlled and rational use.
